Elisa Method For Serum Hepcidin Quantification In Bulgarian Population

Open access

Summary

Hepcidin is a 25-aminoacid cysteine-rich iron regulating peptide. Hepcidin quantification in human blood may provide further insights for the pathogenesis of disorders of iron homeostasis and might prove a valuable tool for clinicians for the differential diagnosis of anaemia. This study describes ELISA immunoassay for hepcidin quantification in human serum. We used a sandwich ELISA method from USCN Life Science inc., that consists of ready to use, pre-coated 96-well strip plate with 2 antihepcidin-25 monoclonal antibodies. A recombinant hepcidin in 16 μg/l concentration is used as a standard; it reconstitutes with 1.0 ml standard diluent to prepare a stock solution. We correlated ELISA results of hepcidin-25 measurements in healthy population with hemodialysis patients. The sandwich ELISA was highly specific for hepcidin-25, having a low limit of quantification of 0.020 μg/l. Hepcidin- 25 concentrations were increased in hemodialysis patients (median 33.05 μg/l, range 22.31 -60.98 μg/l, n = 10) compared with healthy individuals (median 12.41 μg/l, range 6.05-18.53 μg/l, n = 40). The use of 2 monoclonal antibodies in a sandwich ELISA format provides a robust, convenient and not very expensive method for measuring concentrations of the active form of hepcidin. It should help to improve our understanding of the role of hepcidin in regulating iron metabolism.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Andrews N. C. Anemia of infl ammation: the cytokine-hepcidin link. - J. Clin. Invest. 113 2004 1251-1253.

  • 2. Anthony M. et al. Dual-Monoclonal Sandwich ELISA Specifi c for Hepcidin-25. - Clin. Chem. 56 2010 № 11 1725-1732.

  • 3. Ashby D. R. et al. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. - Haematologica 95 2010 505-508.

  • 4. Ashby D. R. et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. - Kidney Int. 75 2009 976-981.

  • 5. Busbridge M. et al. Development of a novel immunoassay for the iron regulatory peptide hepcidin. - Br. J. Biomed. Sci. 66 2009 150-157.

  • 6. De Domenico I. et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. - Mol. Biol. Cell. 18 2007 2569-2578.

  • 7. Donovan A. et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. - Cell. Metab. 1 2005 191-200.

  • 8. Fleming R. E. et W. S. Sly. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. - Proc. Natl. Acad. Sci. USA 98 2001 8160-8162.

  • 9. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. - Best Pract. Res. Clin. Haematol. 18 2005 № 2 171-182.

  • 10. Koliaraki V. et al. A novel immunological assay for hepcidin quantifi cation in human serum. - PLoS One 4 2009 e4581.

  • 11. Krause A. et al. LEAP-1 a novel highly disulfi de-bonded human peptide exhibits antimicrobial activity. - FEBS Lett. 480 2000 № 2-3 147-150.

  • 12. Kulaksiz H. et al. Pro-hepcidin: expression and cell specifi c localisation in the liver and its regulation in hereditary haemochromatosis chronic renal insuffi ciency and renal anaemia. - Gut. 53 2004 № 5 735-743.

  • 13. Luukkonen S. et K. Punnonen. Serum pro-hepcidin concentrations and their responses to oral iron supplementation in healthy subjects manifest considerable inter-individual variation. - Clin. Chem. Lab. Med. 44 2006 1361-1362.

  • 14. Malyszko J. et M. Mysliwiec. Hepcidin in anemia and infl ammation in chronic kidney disease. - Kidney Blood Press. Res. 30 2007 15-30.

  • 15. Nemeth E. et al. (2004) IL-6 mediates hypoferremia of infl ammation by inducing the synthesis of the iron regulatory hormone hepcidin. - J. Clin. Invest. 113 2004 № 9 1271-1276.

  • 16. Nemeth E. et al. Hepcidin regulates cellular iron effl ux by binding to ferroportin and inducing its internalization. - Science 306 2004 № 5704 2090-2093.

  • 17. Park C. H. et al. Hepcidin a urinary antimicrobial peptide synthesized in the liver. - J. Biol. Chem. 276 2001 № 11 7806-7810.

  • 18. Pigeon C. et al. A new mouse liver-specific gene encoding a protein homologous to human antimicrobial peptide hepcidin is overexpressed during iron overload. - J. Biol. Chem. 276 2001 7811-7819.

  • 19. Rivera S. et al. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. - Blood 105 2005 1797-802.

  • 20. Roetto A. et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. - Nat. Genet. 33 2003 21-22.

  • 21. Taes Y. E. et al. (2004) Prohepcidin accumulates in renal insuffi ciency. - Clin. Chem. Lab. Med. 42 2004 № 4 387-389.

  • 22. Theur l I. et al. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. - Blood 107 2006 4142-4148.

  • 23. Valore E. V. et T. Ganz. Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin. - Blood Cells Mol. Dis. 40 2008 № 1 132-138.

  • 24. Van der Putten K. et al. Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure. - Nat. Clin. Pract. Nephrol. 4 2008 47-57.

  • 25. Koliaraki V. et al. A Novel Immunological Assay for Hepcidin Quantifi cation in Human Serum. - PloS one 4 2009 № 2 e4581.

  • 26. Weinstein D. A. et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. - Blood 100 2002 3776-3781.

Search
Journal information
Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 322 173 14
PDF Downloads 106 73 9